TwinStrand Biosciences
TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement
The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.
Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences
TwinStrand's duplex sequencing correction technology can detect ultra-low frequency DNA mutations that are otherwise often obscured by technical noise.